Rapid Revenue Growth Nyxoah demonstrated exceptional sales traction in 2025 with a 347% year-over-year increase in quarterly revenue, signaling strong market acceptance and expanding adoption of its Genio sleep therapy system. This growth indicates a rising demand for innovative sleep disorder treatments, creating opportunities to target healthcare providers and sleep clinics seeking advanced neuromodulation solutions.

Expanding U.S. Presence The successful launch of Nyxoah's commercial activities in the U.S. during the fourth quarter of 2025 resulted in over 145 surgeons trained and 57 accounts activated, highlighting a rapidly growing network of providers familiar with the Genio system. This expansion presents a prime opportunity to engage with new clinical partners and leverage the backlog of US-based sleep centers and ENT specialists.

Strong Market Validation With the Genio device gaining reimbursement approval from both commercial payors and Medicare, Nyxoah's solution is positioned as a cost-effective, accessible treatment option for sleep apnea patients. This favorable reimbursement landscape provides a compelling sales narrative to appeal to payers and healthcare institutions seeking innovative, reimbursable sleep therapies.

Global Manufacturing Capacity Nyxoah is actively expanding its manufacturing footprint to support international growth, indicating readiness to scale sales efforts globally. Sales teams can capitalize on this infrastructure to offer timely equipment delivery to international markets and collaborate with healthcare distributors in jurisdictions with growing demand for minimally invasive sleep disorder treatments.

Investment and Financial Stability With over $27 million in funding and a robust cash reserve of €48 million, Nyxoah is well-positioned to invest in sales and marketing activities, accelerate product adoption, and pursue partnership opportunities. This financial backing reduces sales cycle risks and enables sales teams to focus on customer engagement and market penetration strategies.